Location History:
- San Mateo, CA (US) (2022 - 2023)
- Houston, TX (US) (2023)
Company Filing History:
6 out of 71 
4 out of 3,684 
Years Active: 2022-2025
Title: The Innovative Contributions of Luis Borges
Introduction
Luis Borges is a prominent inventor based in Houston, Texas, known for his significant contributions to the field of biotechnology. With a total of six patents to his name, Borges has made strides in developing innovative solutions for cancer treatment. His work focuses on antibodies that target specific proteins, showcasing his expertise in immunology.
Latest Patents
Among his latest patents, Borges has developed antibodies that bind to the V-domain immunoglobulin-containing suppressor of T-cell activation (VISTA) at acidic pH. These antibodies are designed for use in cancer treatment, specifically targeting human VISTA at acidic pH while minimizing binding at neutral or physiological pH. This innovative approach has the potential to enhance the efficacy of cancer therapies.
Career Highlights
Throughout his career, Luis Borges has worked with notable companies in the biotechnology sector, including Five Prime Therapeutics, Inc. and Bristol-Myers Squibb Company. His experience in these organizations has allowed him to collaborate with leading experts and contribute to groundbreaking research in cancer treatment.
Collaborations
Borges has collaborated with esteemed colleagues such as Robert J. Johnston and Arvind Rajpal. These partnerships have further enriched his research and development efforts, leading to advancements in therapeutic applications.
Conclusion
Luis Borges exemplifies the spirit of innovation in biotechnology through his patents and collaborations. His work on antibodies targeting VISTA represents a significant advancement in cancer treatment, highlighting the importance of continued research and development in this critical field.